During the past decade, Global Health Research Center conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 6 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 6 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Global Health Research Center" #1 sponsor was "Pfizer" with 9 trials, followed by "ACADIA Pharmaceuticals Inc." with 1 trials sponsored, "Bavarian Nordic" with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored and "Evofem Inc." with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Global Health Research Center" #1 collaborator was "Clinical Research Management, Inc." with 1 trials as a collaborator, "Novum Pharmaceutical Research Services" with 1 trials as a collaborator and "SerenaGroup, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Global Health Research Center" are "COVID-19" (5 trials), "Dermatitis, Atopic" (2 trials), "Postmenopausal Osteoporosis" (2 trials), "Atopic Dermatitis" (1 trials) and "Chlamydia Trachomatis Infection" (1 trials). Many other conditions were trialed in "Global Health Research Center" in a lesser frequency.

Most popular intervention types in "Global Health Research Center" are "Drug" (12 trials), "Biological" (5 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Ritonavir" (4 trials), "PF-07321332" (3 trials), "Abrocitinib 100 mg" (1 trials) and "Abrocitinib 200 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Global Health Research Center" are 16 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Global Health Research Center". undefined are not yet recruiting, 2 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Global Health Research Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Global Health Research Center, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".